| __timestamp | AstraZeneca PLC | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 13324000000 | 34916000 |
| Thursday, January 1, 2015 | 11451000000 | 36949000 |
| Friday, January 1, 2016 | 9739000000 | 45240000 |
| Sunday, January 1, 2017 | 10543000000 | 62416000 |
| Monday, January 1, 2018 | 10362000000 | 81289000 |
| Tuesday, January 1, 2019 | 11848000000 | 100359000 |
| Wednesday, January 1, 2020 | 11693000000 | 105326000 |
| Friday, January 1, 2021 | 15680000000 | 122356000 |
| Saturday, January 1, 2022 | 18955000000 | 152848000 |
| Sunday, January 1, 2023 | 18025000000 | 184259000 |
| Monday, January 1, 2024 | 20532000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, operational costs play a pivotal role in shaping a company's financial health. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of AstraZeneca PLC and Corcept Therapeutics Incorporated from 2014 to 2023. AstraZeneca, a global leader, consistently reported higher SG&A expenses, peaking in 2022 with a 42% increase from 2014. In contrast, Corcept Therapeutics, a smaller player, exhibited a remarkable growth trajectory, with SG&A expenses surging by over 400% during the same period. This stark contrast highlights the differing scales and strategies of these companies. While AstraZeneca's expenses reflect its expansive global operations, Corcept's growth underscores its aggressive market expansion. Understanding these trends offers valuable insights into the strategic priorities and market dynamics of these pharmaceutical giants.
Cost Management Insights: SG&A Expenses for Johnson & Johnson and AstraZeneca PLC
Breaking Down SG&A Expenses: AbbVie Inc. vs AstraZeneca PLC
Who Optimizes SG&A Costs Better? AstraZeneca PLC or Neurocrine Biosciences, Inc.
Who Optimizes SG&A Costs Better? AstraZeneca PLC or Insmed Incorporated
AstraZeneca PLC and Grifols, S.A.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of AstraZeneca PLC and Alkermes plc
Operational Costs Compared: SG&A Analysis of AstraZeneca PLC and Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated Trends and Insights
Alnylam Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated: SG&A Expense Trends
Insmed Incorporated and Corcept Therapeutics Incorporated: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc. Trends and Insights